Amplifold
PrivateLast Round
Seed
Dec 10, 2025
Total Funding Raised
$5.82M
Company Overview
Amplifold is a biotechnology company that develops rapid diagnostic tests using DNA-origami nanotechnology to enhance the sensitivity of lateral flow assays.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Advanced Materials, Biotech Equipment
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amplifold Comps
Public and private peers based on sector, stage, and business model.
Amplifold Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 10, 2025 |
Amplifold Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| xista science ventures | Seed |
| Matterwave Ventures | Seed |
| b2venture | Seed |
| Becker Ventures | Seed |
| Bayern Kapital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2026
Dr Federico Bürsgens to join as CEO, effective July 1st, 2026.
- Dec 10, 2025
Raised $5.8M in a Seed round.
Amplifold Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Amplifold's valuation, stock price, and market status.
